The management of retinoblastoma, the most common intraocular malignancy in children,
has changed drastically over the last decade. Landmark developments in local drug …

Retinoblastoma is lethal by metastasis if left untreated, so the primary goal of therapy is to
preserve life, with ocular survival, visual preservation and quality of life as secondary aims …

Persistent or recurrent retinoblastoma (RB) is associated with the presence of vitreous
or/and subretinal seeds in advanced RB and represents a major cause of therapeutic failure …

Objectives To evaluate the long-term treatment outcomes in intraocular retinoblastoma (RB)
including the associated factors for eventual treatment with external beam radiotherapy …

Retinoblastoma stands as a paradigm of success in treating malignancies among pediatric
patients. Over recent decades, the approach to managing retinoblastoma has evolved …

Retinoblastome stellen 6% aller malignen Tumoren bei Kindern unter einem Alter von 5
Jahren dar, die unbehandelt zu Erblindung der betroffenen Augen und Tod durch …

Simple Summary Currently survival from retinoblastoma exceeds 95% in high-
income/resource countries. Life expectancy within the heritable retinoblastoma population is …

Host defense peptides represent an important component of innate immunity. In this work,
we report the anticancer properties of a panel of hyper-charged wholly cationic antimicrobial …

Intraocular retinoblastoma treatment has changed radically over the last decade, leading to
a notable improvement in ocular survival. However, eyes that relapse remain difficult to treat …

In the current era of global health awareness for retinoblastoma (RB), the challenge that lies
ahead of us is providing optimal care for children affected with RB in underdeveloped …